BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21919873)

  • 1. Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival.
    Paratore S; Ciotti MT; Basille M; Vaudry D; Gentile A; Parenti R; Calissano P; Cavallaro S
    Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):210-22. PubMed ID: 21919873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.
    Giunta S; Castorina A; Bucolo C; Magro G; Drago F; D'Agata V
    Peptides; 2012 Sep; 37(1):32-9. PubMed ID: 22721946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM; Riherd DN; O'Malley BW
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide counteracts the impaired adult neural stem cell viability induced by palmitate.
    Mansouri S; Ortsäter H; Pintor Gallego O; Darsalia V; Sjöholm A; Patrone C
    J Neurosci Res; 2012 Apr; 90(4):759-68. PubMed ID: 22183970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K; Connell TD; Higgins D
    J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
    Cavallaro S; Copani A; D'Agata V; Musco S; Petralia S; Ventra C; Stivala F; Travali S; Canonico PL
    Mol Pharmacol; 1996 Jul; 50(1):60-6. PubMed ID: 8700120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
    Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
    J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PACAP and VIP prevent apoptosis in schwannoma cells.
    Castorina A; Tiralongo A; Giunta S; Carnazza ML; Rasi G; D'Agata V
    Brain Res; 2008 Nov; 1241():29-35. PubMed ID: 18835258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
    Basille M; Cartier D; Vaudry D; Lihrmann I; Fournier A; Freger P; Gallo-Payet N; Vaudry H; Gonzalez B
    J Comp Neurol; 2006 Jun; 496(4):468-78. PubMed ID: 16572459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors.
    Spielman LJ; Gibson DL; Klegeris A
    Eur J Cell Biol; 2017 May; 96(3):240-253. PubMed ID: 28336086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GIP-GIPR promotes neurite outgrowth of cortical neurons in Akt dependent manner.
    Teng L; Guan T; Guo B; Ma C; Lin G; Wu R; Xu M; Liu M; Liu Y
    Biochem Biophys Res Commun; 2021 Jan; 534():121-127. PubMed ID: 33321289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development.
    Vaudry D; Gonzalez BJ; Basille M; Fournier A; Vaudry H
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9415-20. PubMed ID: 10430957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway.
    Mazzocchi G; Rebuffat P; Meneghelli V; Malendowicz LK; Tortorella C; Gottardo G; Nussdorfer GG
    Peptides; 1999; 20(5):589-94. PubMed ID: 10465510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M; Vaudry D; Coulouarn Y; Jegou S; Lihrmann I; Fournier A; Vaudry H; Gonzalez B
    J Comp Neurol; 2000 Oct; 425(4):495-509. PubMed ID: 10975876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats.
    Han X; Ran Y; Su M; Liu Y; Tang W; Dong Z; Yu S
    Mol Pain; 2017; 13():1744806917720361. PubMed ID: 28776455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells.
    de Boisvilliers M; Perrin F; Hebache S; Balandre AC; Bensalma S; Garnier A; Vaudry D; Fournier A; Festy F; Muller JM; Chadéneau C
    Peptides; 2016 Apr; 78():30-41. PubMed ID: 26826611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.